logo-loader
viewNanobiotix SA

Nanobiotix happy with first half as cancer trials progress

The Paris-based company is developing the use of a combination of nanoparticles/radiotherapy to treat a range of cancers

picture of radiotherapy machine
Nanobiotix is targeting a range of cancers

Cancer treatment pioneer Nanobiotix (EPA:NANO) made good progress in the first half of 2017, Philippe Mauberna, chief financial officer said today.

The Paris-based company is developing the use of a combination of nanoparticles/radiotherapy to treat a range of cancers.

READ: Nanobiotix technology has "blockbuster potential", according to American investment bank

Mauberna pointed to the recent recommendation for the Phase II/III trial in Soft Tissue Sarcoma to continue and the successful clinical results from the Phase I/II Trial of lead product NBTXR3 in head & neck cancer.

A €25mln funding in April will enable the group to expand NBTXR3's clinical programme in head and neck cancer and take the Immuno-Oncology programme into patients, he added.

Revenues in the six months to June were €1.9m (H1 (€3.0m) with an after tax loss of €12mln (€10mln).

READ: Nanobiotix highlights more encouraging immunotherapy data from its cancer treatment

Cash at the end of June was €31mln (H1 2016: €25mln). 

Quick facts: Nanobiotix SA

Price: 12.85 GBX

EPA:NANO
Market: EPA
Market Cap: £36.78 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Impax Asset Management reveals key themes investors should...

Impax Asset Management Group PLC (LON:IPX) Head of Client Services and Business Development David Richardson tells Proactive key themes investors should look out for in 2020.  Richardson says he's seeing expansion in developing renewable energy projects in Europe, increased interested in...

6 hours, 52 minutes ago

2 min read